Sclerosing cholangitis and inflammatory bowel disease: which comes first?

Rossijskij Vestnik Perinatologii i Pediatrii

G. V. Volynets¹  A. V. Nikitin² 

[1] Veltischev Research and Clinical Institute for Pediatrics of the Pirogov Russian National Research Medical University;Pirogov Russian National Research Medical University;

关键词: children;    sclerosing cholangitis;    inflammatory bowel disease;    crohn’s disease;    ulcerative colitis;   

DOI  :  10.21508/1027-4065-2021-66-1-39-46

来源: DOAJ

【 摘 要 】

Sclerosing cholangitis is one of the most common hepatologic extraintestinal manifestations of inflammatory bowel disease. The article discusses the phenotype of the combination of sclerosing cholangitis and inflammatory bowel disease. The authors present their theories of the etiopathogenesis of sclerosing cholangitis in patients with inflammatory bowel disease, as well as some features of the phenotype of both mixed and monogenic forms of diseases.Sclerosing cholangitis in combination with inflammatory bowel disease is commonly associated with pancolitis, but the endoscopically visualized activity of inflammatory bowel diseases is significantly lower and clinical symptoms are less pronounced. The authors have established that the patients with the combination of sclerosing cholangitis and inflammatory bowel disease are at the increased risk of developing malignant neoplasms. The formation mechanisms of a combination of inflammatory bowel disease and sclerosing cholangitis remain poorly understood, although this pathology is influenced by lymphocytic cross-reactivity, aberrant recognition of microbiotic epitopes and intestinal microbiota imbalance. New biological agents aimed at correcting the interaction between the immune system and target organs may provide new ways of treatment for sclerosing cholangitis associated with inflammatory bowel disease.

【 授权许可】

Unknown